BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23360021)

  • 1. Management of atrial fibrillation.
    Kahali D; Mondal S
    J Indian Med Assoc; 2012 May; 110(5):297-301. PubMed ID: 23360021
    [No Abstract]   [Full Text] [Related]  

  • 2. The editor's roundtable: medical management of atrial fibrillation.
    Friedewald VE; Kowal RC; Olshansky B; Yancy CW; Roberts WC
    Am J Cardiol; 2012 Feb; 109(4):563-9. PubMed ID: 22293222
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrial Fibrillation in Athletes.
    Goudis CA; Ntalas IV; Ketikoglou DG
    Cardiol Rev; 2015; 23(5):247-51. PubMed ID: 25479068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic options in the prevention of atrial fibrillation.
    Archontakis S; Sideris S
    Hellenic J Cardiol; 2018; 59(5):279-280. PubMed ID: 30579978
    [No Abstract]   [Full Text] [Related]  

  • 5. Upstream therapies after pulmonary vein ablation: five negative studies--what's next?
    Savelieva I; Camm AJ
    Europace; 2010 Nov; 12(11):1509-13. PubMed ID: 20974763
    [No Abstract]   [Full Text] [Related]  

  • 6. [AIAC Guidelines on the management and treatment of atrial fibrillation. Update 2013. Associazione Italiana di Aritmologia e Cardiostimolazione].
    Raviele A; Disertori M; Alboni P; Bertaglia E; Botto G; Brignole M; Cappato R; Capucci A; Del Greco M; De Ponti R; Di Biase M; Di Pasquale G; Gulizia M; Lombardi F; Themistoclakis S; Tritto M;
    G Ital Cardiol (Rome); 2013 Mar; 14(3):215-40. PubMed ID: 23474607
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of atrial fibrillation -- the goal is frequency control].
    Meinertz T
    Dtsch Med Wochenschr; 2006 Sep; 131(39):2159. PubMed ID: 16991033
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute and chronic management of atrial fibrillation in patients with late-stage CKD.
    Aronow WS
    Am J Kidney Dis; 2009 Apr; 53(4):701-10. PubMed ID: 19324248
    [No Abstract]   [Full Text] [Related]  

  • 9. Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.
    Guirguis-Blake J
    Am Fam Physician; 2012 Jul; 86(1):21-3. PubMed ID: 22962909
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
    Camm AJ; Kirchhof P; Lip GY; Schotten U; Savelieva I; Ernst S; Van Gelder IC; Al-Attar N; Hindricks G; Prendergast B; Heidbuchel H; Alfieri O; Angelini A; Atar D; Colonna P; De Caterina R; De Sutter J; Goette A; Gorenek B; Heldal M; Hohloser SH; Kolh P; Le Heuzey JY; Ponikowski P; Rutten FH;
    Europace; 2010 Oct; 12(10):1360-420. PubMed ID: 20876603
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rhythm control and rate control as therapy for patients with atrial fibrillation].
    Nishimura H
    Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):292-8. PubMed ID: 16536080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of atrial fibrillation].
    Kirchhof P; Breithardt G
    Internist (Berl); 2007 Aug; 48(8):819-29; quiz 830-1. PubMed ID: 17632695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the use of non-antiarrhythmic drugs and postoperative atrial fibrillation.
    Ozaydin M; Turker Y; Peker O; Erdogan D; Varol E; Dogan A; Ibrisim E
    Int J Cardiol; 2010 Oct; 144(2):304-6. PubMed ID: 19282043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention following myocardial infarction: a clinical update.
    Isted A; Williams R; Oakeshott P
    Br J Gen Pract; 2018 Mar; 68(668):151-152. PubMed ID: 29472228
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
    Lally JA; Gnall EM; Seltzer J; Kowey PR
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options].
    Boldt LH; Rolf S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2349-54. PubMed ID: 18958832
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vascular endothelial function].
    Naruse K
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():568-72. PubMed ID: 21667513
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
    Tayebjee MH; Creta A; Moder S; Hunter RJ; Earley MJ; Dhinoja MB; Schilling RJ
    Europace; 2010 Nov; 12(11):1537-42. PubMed ID: 20682557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of STEMI in low- and middle-income countries.
    Baliga RR; Bahl VK; Alexander T; Mullasari A; Manga P; Dec GW; Narula J
    Glob Heart; 2014 Dec; 9(4):469-510. PubMed ID: 25592801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.